Home NDC 0143-9006 AcetaZOLAMIDE
Product NDC 0143-9006
11-digit product format 001439006
Labeler code 0143
Product ID 0143-9006_6468455a-a638-4ef0-8bce-41afa7f24c66
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Acetazolamide
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Hikma Pharmaceuticals USA Inc.
Application ANDA040089
Marketing category ANDA
Marketing start 1996-05-01
Substance ACETAZOLAMIDE SODIUM
Active strength 500 mg/1
Pharmacologic classes Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A040089-001 ACETAZOLAMIDE SODIUM ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A040089-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A040089-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP 1995-02-28 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
Additional Listing Data#
Finished product Yes
Brand name base AcetaZOLAMIDE
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ACETAZOLAMIDE SODIUM 500 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 429ZT169UH Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 307702 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0143-9006-01 AcetaZOLAMIDE 1 in 1 VIAL INJECTION, POWDER, LYOPHILIZED, 1 4 0143-9006-01 AcetaZOLAMIDE 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0143-9006 ACETAZOLAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HIKMA PHARMACEUTICALS USA INC.] 3 Current NDC, Legacy NDC, 2 package rows 20250209_5502e5ba-9b5e-460a-855f-60534b625461.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0143-9006-01 00143900601 1 VIAL in 1 CARTON (0143-9006-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL 1 vial 1996-05-01 0000-00-00 No No Current